Camilleri, M. et al. Chronic constipation. Nat Rev Dis Primers. 3, 17095 (2017).
Peery, A. F. et al. Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States: Update 2021. Gastroenterology. 162(2), 621–644 (2022).
Sumida, K. et al. Constipation and risk of death and cardiovascular events. Atherosclerosis. 281, 114–120 (2019).
Sundboll, J. et al. Constipation and risk of cardiovascular diseases: A Danish population-based matched cohort study. BMJ Open. 10(9), e037080 (2020).
Salmoirago-Blotcher, E., Crawford, S., Jackson, E., Ockene, J. & Ockene, I. Constipation and risk of cardiovascular disease among postmenopausal women. Am. J. Med. 124(8), 714–723 (2011).
Sumida, K. et al. Constipation and incident CKD. J. Am. Soc. Nephrol. 28(4), 1248–1258 (2017).
Suares, N. C. & Ford, A. C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am. J. Gastroenterol. 106(9), 1582–1591 (2011).
Ruszkowski, J., Majkutewicz, K., Heleniak, Z., Witkowski, J. M. & Debska-Slizien, A. Prevalence and severity of lower gastrointestinal symptoms amongst non-dialysis chronic kidney disease patients: a systematic review and meta-analysis. J. Clin. Med. 11(21), 6363 (2022).
Sumida, K., Yamagata, K. & Kovesdy, C. P. Constipation in CKD. Kidney Int. Rep. 5(2), 121–134 (2020).
Ikee, R., Yano, K. & Tsuru, T. Constipation in chronic kidney disease: It is time to reconsider. Renal Replacement Therapy. 5(1), 51 (2019).
Group KDIGOKCW. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 2013(3), 1–150 (2012).
Perrone, R. D., Coons, S. J., Cavanaugh, K., Finkelstein, F. & Meyer, K. B. Patient-reported outcomes in clinical trials of CKD-related therapies: Report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration. Am. J. Kidney Dis. 62(6), 1046–1057 (2013).
Davison, S. N. et al. Patient-reported outcome measures in the care of in-centre hemodialysis patients. J. Patient Rep. Outcomes 5(Suppl 2), 93 (2021).
Pan, R. et al. Crosstalk between the gut microbiome and colonic motility in chronic constipation: Potential mechanisms and microbiota modulation. Nutrients. 14(18), 3704 (2022).
Krukowski, H. et al. Gut microbiome studies in CKD: Opportunities, pitfalls and therapeutic potential. Nat. Rev. Nephrol. 19(2), 87–101 (2023).
Kim, J. A., Yoon, S., Kim, L. Y. & Kim, D. S. Towards actualizing the value potential of korea health insurance review and assessment (HIRA) data as a resource for health research: Strengths, limitations, applications, and strategies for optimal use of HIRA data. J. Korean Med. Sci. 32(5), 718–728 (2017).
Kim, L., Kim, J. A. & Kim, S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol. Health 36, e2014008 (2014).
Hwang, S. et al. Changes in acute kidney injury epidemiology in critically ill patients: A population-based cohort study in Korea. Ann. Intensive Care. 9(1), 65 (2019).
Park, S. et al. Disparity in accessibility to and prognosis of kidney transplantation according to economic inequality in South Korea: a widening gap after expansion of insurance coverage. Transplantation. 105(2), 404–412 (2021).
Lim, E. J. et al. Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea. J. Transl. Med. 19(1), 502 (2021).
Jeong, H., Choi, E., Suh, A., Yoo, M. & Kim, B. Risk of cardiovascular disease associated with febuxostat versus allopurinol use in patients with gout: A retrospective cohort study in Korea. Rheumatol. Int. 43(2), 265–281 (2023).
Hripcsak, G. et al. Observational health data sciences and informatics (OHDSI): Opportunities for observational researchers. Stud. Health Technol. Inf. 216, 574–578 (2015).
Shim, Y. J., Choi, H. G. & Wee, J. H. Association between chronic kidney disease and sudden sensorineural hearing loss: A longitudinal follow-up studies using ICD-10 codes in a National Health Screening Cohort. J. Clin. Med. 12(8), 2861 (2023).
Kim, S. H., Jo, M. W., Go, D. S., Ryu, D. R. & Park, J. Economic burden of chronic kidney disease in Korea using national sample cohort. J. Nephrol. 30(6), 787–793 (2017).
Park, R. W. The distributed research network, observational health data sciences and informatics, and the South Korean Research Network. Korean J. Med. 94(4), 309–314 (2019).
The Lancet Regional Health-Western P. South Korea’s population shift: challenges and opportunities. Lancet Reg. Health West Pac. 36, 100865 (2023).
Yoon, S. Y. et al. National trends in the prevalence of chronic kidney disease among Korean adults, 2007–2020. Sci. Rep. 13(1), 5831 (2023).
Hong, Y. A. et al. Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS). Kidney Res. Clin. Pract. 40(1), 52–61 (2021).
Branch, R. L. & Butt, T. F. Drug-induced constipation. Adverse Drug React. Bull. 257, 987–990 (2009).
Grove, B. E. et al. Patient-reported outcome measures for clinical decision-making in outpatient follow-up: validity and reliability of a renal disease questionnaire. J. Patient-Rep. Outcomes. 5(1), 107 (2021).
Yapa, H. E., Purtell, L., Chambers, S. & Bonner, A. Alterations in symptoms and health-related quality of life as kidney function deteriorates: A cross-sectional study. J. Clin. Nurs. 30(11–12), 1787–1796 (2021).
Ruszkowski, J. et al. Constipation and the quality of life in conservatively treated chronic kidney disease patients: A cross-sectional study. Int. J. Med. Sci. 17(18), 2954–2963 (2020).
Lee, S. J. & Jeon, J. Relationship between symptom clusters and quality of life in patients at stages 2 to 4 chronic kidney disease in Korea. Appl. Nurs. Res. 28(4), e13–e19 (2015).
Kim, J. C., Young Do, J. & Kang, S. H. Comparisons of physical activity and understanding of the importance of exercise according to dialysis modality in maintenance dialysis patients. Sci. Rep. 11(1), 21487 (2021).
Yasuda, G. et al. Prevalence of constipation in continuous ambulatory peritoneal dialysis patients and comparison with hemodialysis patients. Am. J. Kidney Dis. 39(6), 1292–1299 (2002).
Zhang, J. et al. Health-related quality of life in dialysis patients with constipation: a cross-sectional study. Patient Prefer. Adher. 7, 589–594 (2013).
Ramos, C. I., Andrade de Lima, A. F., Grilli, D. G. & Cuppari, L. The short-term effects of olive oil and flaxseed oil for the treatment of constipation in hemodialysis patients. J. Ren. Nutr. 25(1), 50–56 (2015).
Dos Santos, R. G. et al. Higher frequency of fruit intake is associated with a lower risk of constipation in hemodialysis patients: a multicenter study. J. Ren. Nutr. 31(1), 85–89 (2021).
Chan, S. et al. Patient-reported gastrointestinal symptoms and the association with quality of life following kidney transplantation. Kidney Int. Rep. 6(1), 138–145 (2021).
Fatly ZA, Betjes MG, van Gestel J, Verschragen M, de Weerd AE. the burden of gastrointestinal complaints in kidney transplant recipients using tacrolimus with and without mycophenolate mofetil: A randomized controlled study. Front. Nephrol. 2, 93395 (2022).
Xiao, J. et al. Organ transplantation and gut microbiota: Current reviews and future challenges. Am. J. Transl. Res. 10(11), 3330–3344 (2018).
Sueyoshi, M. et al. Effects of lactulose on renal function and gut microbiota in adenine-induced chronic kidney disease rats. Clin. Exp. Nephrol. 23(7), 908–919 (2019).
Tayebi-Khosroshahi, H. et al. The effect of lactulose supplementation on fecal microflora of patients with chronic kidney disease: A randomized clinical trial. J. Renal Inj. Prev. 5(3), 162–167 (2016).
Cho, Y. S. et al. 2022 Seoul consensus on clinical practice guidelines for functional constipation. J. Neurogastroenterol. Motil. 29(3), 271–305 (2023).
Danhof, I. E. Pharmacology, toxicology, clinical efficacy, and adverse effects of calcium polycarbophil, an enteral hydrosorptive agent. Pharmacotherapy 2(1), 18–28 (1982).
Ng, P., Lei, K., Teng, L., Thomas, A. & Battistella, M. Development and validation of a constipation treatment toolkit for patients on hemodialysis. Hemodial. Int. 26(1), 66–73 (2022).
Talley, N. J., Jones, M., Nuyts, G. & Dubois, D. Risk factors for chronic constipation based on a general practice sample. Am. J. Gastroenterol. 98(5), 1107–1111 (2003).
Xu, Y., Amdanee, N. & Zhang, X. Antipsychotic-induced constipation: A review of the pathogenesis, clinical diagnosis, and treatment. CNS Drugs. 35(12), 1265–1274 (2021).
Shirazian, S. et al. Depression in chronic kidney disease and end-stage renal disease: similarities and differences in diagnosis, epidemiology, and management. Kidney Int. Rep. 2(1), 94–107 (2017).
Tan, L. H. et al. Insomnia and poor sleep in CKD: A systematic review and meta-analysis. Kidney Med. 4(5), 100458 (2022).
Ramos, C. I. et al. Bowel habits and the association with uremic toxins in non-dialysis-dependent chronic kidney disease patients. J. Ren. Nutr. 30(1), 31–35 (2020).
Pereira, N. B. F. et al. Influence of bowel habits on gut-derived toxins in peritoneal dialysis patients. J. Nephrol. 33(5), 1049–1057 (2020).
Vaziri, N. D. et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 83(2), 308–315 (2013).
Jin, D. C. & Han, J. S. Renal replacement therapy in Korea, 2012. Kidney Res. Clin. Pract. 33(1), 9–18 (2014).
- The Renal Warrior Project. Join Now
- Source: https://www.nature.com/articles/s41598-024-57382-7